Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00105950
First received: March 18, 2005
Last updated: May 4, 2015
Last verified: May 2015